Current Month 2013
Article Features
  Acupuncture Reduces Hot Flashes in Breast Cancer Survivors
Biomarker May Predict Who Will Benefit from Targeted Therapy for HER2-Negative Breast Cancer
Cancer Preventive Surgery Could Become a Thing of the Past, New Research Suggests
Cell-Surface Discovery Could Fundamentally Alter Cancer Treatment
Computer-Aided Detection Does Not Improve Breast Cancer Screening
Coverage of Celebrity’s Mastectomy Has Improved Awareness of Reconstructive Breast Surgery Options
Discovery of Genetic Differences Between Relapsing and Non-Relapsing Breast Cancers
Genomic Differences Between Breast Cancers of African-American and White Women Identified
Hormonal Therapy May Prevent Ovarian Failure and Preserve Fertility in Breast Cancer
Initial Results Published From TAILORx Breast Cancer Trial
Mediterranean Diet Plus Olive Oil Associated with Reduced Breast Cancer Risk
Metastatic Breast Cancer Cells Turn on Stem Cell Genes
Molecular ‘Feedback Loop' May Explain Tamoxifen Resistance in Patients with Breast Cancer
MRI Technique Could Reduce Need for Breast Biopsies
Natural Compound Luteolin Could Reduce Breast Cancer Risk in Some Women
New Approach Found to Tackle Breast Cancer Resistance to Hormone Therapy
New Approach to Mammograms Could Improve Reliability
Prophylactic Surgery Nearly Doubles in Men with Breast Cancer
Research Discovery Leads to Potential Diagnostic Test for Assessing Breast Cancer Recurrence
Researchers Identify the Gene Responsible for Metastasis of Breast Cancer to the Bone
Surgical Probe Seeks Out Where Cancer Ends and Healthy Tissue Begins
Treatment of Elderly Breast Cancer Patients Varies Between Different European Countries
Underdetection, Not Overdiagnosis, Is The Real Problem in Breast Cancer Screening
Using Artificial Intelligence to Improve Breast Cancer Patient Outcomes
Virus in Cattle Linked to Human Breast Cancer

Underdetection, Not Overdiagnosis, Is The Real Problem in Breast Cancer Screening

While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.

A new review article discusses the topics of overdiagnosis and overtreatment and the role of providers and technology to address the issues in the context of population health. The article appears in the journal Population Health Management.

The article provides a detailed review of the benefits and limitations of current screening mammography practices, and outlines the complexities of the issues from both clinical and methodological perspectives. Coauthors Elizabeth Morris, MD, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College (New York, NY), Stephen Feig, MD, University of California Irvine Medical Center and School of Medicine, Madeline Drexler, Harvard T.H. Chan School of Public Health (Boston, MA), and Constance Lehman, MD, Massachusetts General Hospital (Boston, MA) state that "the key goal should not be less diagnosis but better information and improved treatment decision tools."

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon